Catherine Campbell

Dr. Catherine Campbell joined DARPA as a program manager in January 2022. With over two decades of professional experience in molecular and marine biology, microbiology, and bioinformatics, her interests have focused on the analysis of population-based experiments designed to study both human and animal models of disease.

Prior to coming to DARPA, Campbell designed informatics systems for government biodefense applications, facilitated in silico identification of medical countermeasures, and developed methods for pathogen identification and detection. Past projects have included directing the development of informatics tools, developing institution-wide training programs for NIH researchers, and participating in collaborative neurological disease research and customized data analysis with both clinical and basic science investigators. Her research work has encompassed both laboratory experiments and statistical and bioinformatic analysis of several important diseases including biodefense agents, Gaucher’s disease, multiple sclerosis, chronic fatigue syndrome, and neurofibromatosis.

Campbell earned a Bachelor of Science degree in microbiology from Cornell University, and Master of Science and Doctor of Philosophy degrees in marine biology from the University of Miami. She has published 20 peer-reviewed journal articles, given numerous technical presentations, and has served as a reviewer on 15 government science and technology review panels.